CAS: 1883423-59-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | MSC2530818 REF: IN-DA01EOQ5CAS: 1883423-59-3 | % | 54,00 €~503,00 € | Mar 07 Ene 25 |
 | MSC2530818 REF: TM-TQ0266CAS: 1883423-59-3 | 99.33% | 65,00 €~1.003,00 € | Mar 14 Ene 25 |
 | MSC2530818 REF: 3D-IAD42359CAS: 1883423-59-3 | Min. 95% | A consultar | Mar 18 Feb 25 |
Ref: IN-DA01EOQ5
| 5mg | 54,00 € | ||
| 10mg | 69,00 € | ||
| 25mg | 110,00 € | ||
| 50mg | 186,00 € | ||
| 100mg | 224,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
MSC2530818
CAS:1883423-59-3
MSC2530818 is an effective, selective and orally available CDK8 inhibitor (IC50: 2.6 nM).
Fórmula:
C18H17ClN4O
Pureza:
99.33%
Forma y color:
Solid
Peso molecular:
340.81
Ref: TM-TQ0266
| 1mg | 65,00 € | ||
| 5mg | 143,00 € | ||
| 10mg | 227,00 € | ||
| 25mg | 497,00 € | ||
| 50mg | 723,00 € | ||
| 100mg | 1.003,00 € | ||
| 1mL*10mM (DMSO) | 159,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
MSC2530818
CAS:1883423-59-3
MSC2530818 is a small molecule kinase inhibitor that is selective for the epidermal growth factor …
Fórmula:
C18H17ClN4O
Pureza:
Min. 95%
Peso molecular:
340.81 g/mol
Ref: 3D-IAD42359
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
